When the Narcotics Control Bureau, working alongside state police and central agencies, launched Operation Trident to break up a transnational drug-trafficking cartel operating across India, Myanmar, and Bangladesh, the operation did more than yield arrests. It illustrated, in operational detail, how deeply India is embedded in the geography of global narcotics flows. The cartel was not a local enterprise that had gone rogue. It was a node in a network stretching from Southeast Asian poppy fields to Indian streets.
That network draws its supply from two directions. To India's east lies the Golden Triangle (Myanmar, Laos, and Thailand), Southeast Asia's principal opium-producing region and one of the oldest narcotics supply routes to Europe and North America. To the northwest sits the Golden Crescent, comprising Afghanistan, Iran, and Pakistan. India sits between these two production zones, which is less a coincidence of geography than a structural condition that any serious policy response must reckon with.
The geographic pressure is compounded by several other vulnerabilities. India shares over 15,000 km of land borders and a coastline exceeding 11,000 km. Porous stretches along Myanmar, Nepal, and Bangladesh run through difficult terrain where formal surveillance is thin and informal routes are well-established. Punjab, Manipur, and Assam bear the most visible burden.
India's pharmaceutical and precursor-chemical manufacturing base adds a second layer of risk. As one of the world's largest producers in this sector, India generates raw inputs that, if diverted through weak regulatory oversight, can feed the illegal manufacture of synthetic drugs. Drug proceeds have also demonstrably funded anti-India activities along the western border, linking the narcotics trade to insurgency and organised crime in ways that make it a national security concern, not merely a public health one.
The consequences cascade outward. Drug abuse erodes economic productivity, raises healthcare costs, fractures families, and generates the kind of social stigma that pushes users away from treatment rather than toward it.
India's legal foundation remains the Narcotic Drugs and Psychotropic Substances Act, 1985 (NDPS Act), which prohibits production, possession, sale, and consumption of illicit drugs and prescribes penalties for violations. Layered on top is an expanding institutional apparatus. The NCB's DarkNet Monitoring Cell tracks online drug sales, an acknowledgement that trafficking has migrated to encrypted digital marketplaces. The Nasha Mukt Bharat Abhiyaan, launched in 2020, anchors the demand-reduction effort through awareness campaigns.
The most ambitious recent initiative is the Three-Year Roadmap to make India drug-free by 2029, built on four pillars: intelligence and operation-based enforcement; precursor and synthetic drug control; demand and harm reduction; and capacity building and coordination. Under this framework, agencies including the BSF, CISF, Indian Coast Guard, Customs, and DRI will conduct risk-based profiling and install scanners at land borders, ports, airports, and cargo facilities. The CBI, Ministry of External Affairs, and Interpol will pursue fugitives abroad, while the Enforcement Directorate, Financial Intelligence Unit, and the banking system will follow the money.
The Kashi Declaration, a five-year roadmap for a drug-free India signed at the Youth Spiritual Summit in Varanasi, complements this with a civil-society and youth-engagement dimension. India has also signed bilateral agreements with 27 countries and MoUs with 16 countries to combat illicit trafficking.
At the global governance level, the United Nations Office on Drugs and Crime (UNODC) leads international awareness and enforcement coordination, while the International Narcotics Control Board (INCB) monitors compliance with drug control treaties. India's engagement with both bodies matters, but harmonised extradition treaties and integrated real-time intelligence platforms remain works in progress.
The honest assessment is that India's response is architecturally serious but unevenly implemented. Enforcement capacity is growing; rehabilitation infrastructure is not keeping pace. A drug-free India by 2047 is a stated national goal, but it will remain aspirational unless demand-side investment in mental health support, community rehabilitation, and youth engagement matches the resources flowing into interdiction.
With reference to Operation Trident, which of the following correctly describes the geographical scope of the transnational drug-trafficking cartel it targeted?
Which of the following best describes the four pillars of India's Three-Year Roadmap to make India drug-free by 2029?
The Kashi Declaration, mentioned in the context of India's anti-drug efforts, was signed at which event and in which city?
